Postmarketing surveillance - Demise or rebirth?

被引：0
|
作者：
Waller, PC
Wood, SM
Langman, MJS
Breckenridge, AM
Rawlins, MD
机构：
来源：
ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS | 1996年 / 15卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：71 / 72
页数：2
相关论文
共 50 条
  • [41] ICD Leads and Postmarketing Surveillance
    Carlson, Mark D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 967 - 967
  • [42] PRESCRIBER PROFILE AND POSTMARKETING SURVEILLANCE
    INMAN, W
    PEARCE, G
    LANCET, 1993, 342 (8872): : 658 - 661
  • [43] Postmarketing surveillance for drug safety
    Holden, WL
    Scarazzini, LJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 503 - 503
  • [44] PRESCRIBER PROFILE AND POSTMARKETING SURVEILLANCE
    INMAN, WHW
    PEARCE, G
    LANCET, 1993, 342 (8885): : 1491 - 1491
  • [45] DATA QUALITY IN POSTMARKETING SURVEILLANCE
    GIRARD, M
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1986, 5 (02): : 87 - 95
  • [46] POSTMARKETING SURVEILLANCE OF DRUGS - REPLY
    ROESER, HP
    ROHAN, AP
    MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (08) : 567 - 567
  • [47] Passive postmarketing surveillance not enough
    Reactions Weekly, 2000, 807 (1) : 4 - 4
  • [48] Pemoline hepatotoxicity and postmarketing surveillance
    Safer, DJ
    Zito, JM
    Gardner, JF
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (06): : 622 - 629
  • [49] TECHNIQUES OF POSTMARKETING SURVEILLANCE - AN OVERVIEW
    CARSON, JL
    STROM, BL
    MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1986, 1 (04): : 237 - 246
  • [50] NEW APPROACHES TO POSTMARKETING SURVEILLANCE
    FISHER, S
    BRYANT, SG
    KLUGE, RM
    PSYCHOPHARMACOLOGY, 1986, 90 (03) : 347 - 350
12345